Trial record 1 of 1 for:
cabotegravir | LATITUDE | Phase 3 | NIH
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03635788 |
|
Recruitment Status :
Recruiting
First Posted : August 17, 2018
Last Update Posted : December 15, 2023
|
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
ViiV Healthcare
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2025 |
| Estimated Study Completion Date : | December 31, 2026 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):